The effects of aldose reductase inhibition with ponalrestat on changes in vascular function in streptozotocin diabetic rats

作者: Donna J. Otter , Russell Chess-Williams

DOI: 10.1111/J.1476-5381.1994.TB17028.X

关键词: Sodium nitroprussidePolyol pathwayAldose reductase inhibitorCarbacholPhenylephrineChemistryAldose reductaseForskolinStreptozotocinInternal medicineEndocrinology

摘要: 1. The responses of rat isolated aortae to vasoconstrictor and vasodilator agents have been studied in 14-day streptozotocin-diabetic rats. effects treatment with the aldose reductase inhibitor, ponalrestat, on these also investigated. 2. Maximum contractile aortic sensitivity phenylephrine were significantly enhanced diabetic aortae. 3. In contrast, endothelium-dependent relaxations carbachol depressed rats, whilst endothelium-independent forskolin sodium nitroprusside unchanged. 4. Pretreatment ponalrestat (25 mg kg-1, daily) prevented both maximum from Ponalrestat however, had no effect reduced EC50 values observed tissues animals. 5. It is concluded that prevents depression induced by diabetes 14 days duration, suggesting polyol pathway involved vascular changes. does not prevent increase alpha 1-adrenoceptor agonists.

参考文章(30)
Dushan Dvornik, Chapter 17. Chronic Complications of Diabetes Annual Reports in Medicinal Chemistry. ,vol. 13, pp. 159- 166 ,(1978) , 10.1016/S0065-7743(08)60620-X
G. E. McVeigh, L. T. McGrath, G. M. Brennan, G. D. Johnston, J. W. Andrews, J. R. Hayes, W. R. Henry, B. J. McDermott, Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. ,vol. 35, pp. 771- 776 ,(1992) , 10.1007/BF00429099
T. M GRIFFITH, D. H EDWARDS, A. C NEWBY, M. J LEWIS, A. H HENDERSON, Production of endothelium derived relaxant factor is dependent on oxidative phosphorylation and extracellular calcium Cardiovascular Research. ,vol. 20, pp. 7- 12 ,(1986) , 10.1093/CVR/20.1.7
Clare E. Austin, Russell Chess-Williams, Diabetes-induced changes in cardiac β-adrenoceptor responsiveness : effects of aldose reductase inhibition with ponalrestat British Journal of Pharmacology. ,vol. 102, pp. 478- 482 ,(1991) , 10.1111/J.1476-5381.1991.TB12197.X
Philip R. Steinmetz, Christine Balko, Kenneth H. Gabbay, The sorbitol pathway and the complications of diabetes. The New England Journal of Medicine. ,vol. 288, pp. 831- 836 ,(1973) , 10.1056/NEJM197304192881609
Kenneth B. Seamon, John W. Daly, Forskolin, cyclic AMP and cellular physiology Trends in Pharmacological Sciences. ,vol. 4, pp. 120- 123 ,(1983) , 10.1016/0165-6147(83)90326-7
Kim H. Harris, Kathleen M. MacLeod, Influence of the endothelium on contractile responses of arteries from diabetic rats European Journal of Pharmacology. ,vol. 153, pp. 55- 64 ,(1988) , 10.1016/0014-2999(88)90587-0
A. R. Christlieb, H.-U. Janka, B. Kraus, R. E. Gleason, E. A. Icasas-Cabral, L. M. Aiello, B. V. Cabral, A. Solano, Vascular Reactivity to Angiotensin II and to Norepinephrine in Diabetic Subjects Diabetes. ,vol. 25, pp. 268- 274 ,(1976) , 10.2337/DIAB.25.4.268
Carlo Beretta-Piccoli, Gérald Keusch, Zeev Glück, Muhamed Mujagic, Martin Grimm, Andreas Meier, Walter H. Ziegler, Peter Weidmann, Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus The American Journal of Medicine. ,vol. 67, pp. 779- 784 ,(1979) , 10.1016/0002-9343(79)90734-4
K. M. MacLeod, J. H. McNeill, The influence of chronic experimental diabetes on contractile responses of rat isolated blood vessels. Canadian Journal of Physiology and Pharmacology. ,vol. 63, pp. 52- 57 ,(1985) , 10.1139/Y85-009